Esperion names pharma CFO to board

ANN ARBOR—The Ann Arbor cholesterol-lowering drug developer Esperino Therapeutics Inc. (NASDAQ: ESPR) announced the appointment of Alan Fuhrman as a Class III director, with a term expiring at the 2022 …

U.S. robot orders up, but revenue down

ANN ARBOR—The Robotic Industries Association (RIA), part of the Association for Advancing Automation (A3), announced that orders of industrial robotic units rose 1.6 percent in North America in 2019, with …